Freed Martin I 4
4 · Solid Biosciences Inc. · Filed Jun 18, 2020
Insider Transaction Report
Form 4
Freed Martin I
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2020-06-16+30,000→ 30,000 totalExercise: $3.03Exp: 2030-06-16→ Common Stock (30,000 underlying) - Award
Director Stock Option (Right to Buy)
2020-06-16+10,000→ 10,000 totalExercise: $3.03Exp: 2030-06-16→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.
- [F2]This option was granted on June 16, 2020 to members of the Clinical Committee of the Board of Directors and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.